Table 1.
EMG and urodynamic properties recorded during voiding in chronically implanted rats
Property | Daily | Dark | Light | P Value, Dark vs. Lighta |
---|---|---|---|---|
Number of voidsb | 22.4 ± 1.4 | 15.0 ± 1.0 | 7.3 ± 0.5 | 0.0001 |
Intervoid interval, s | 75.5 ± 4.1 | 56.2 ± 3.4 | 99.9 ± 5.6 | 0.0001 |
Daily urine output, g/200 g body wtc | 9.8 ± 0.6 | 5.5 ± 0.4 | 4.2 ± 0.3 | 0.0001 |
Urine output/void, g/200 g body wt | 0.49 ± 0.03 | 0.40 ± 0.03 | 0.60 ± 0.03 | 0.0001 |
Void duration, s | 2.2 ± 0.1 | 2.0 ± 0.1 | 2.5 ± 0.1 | 0.0001 |
EMG amplitude, μV | 28.6 ± 2.7 | 29.9 ± 2.8 | 28.5 ± 2.7 | 0.002 |
Bursting powerd, % of total | 14.8 ± 1.4 | 14.3 ± 1.3 | 15.9 ± 1.6 | 0.005 |
Bursting timee, s | 0.93 ± 0.14 | 0.82 ± 0.14 | 1.16 ± 0.17 | 0.001 |
Dominant frequencyf, Hz | 6.7 ± 0.1 | 7.1 ± 0.1 | 6.7 ± 0.1 | 0.006 |
Values are means ± SE.
EMG, electromyography.
Analysis by paired t-test within each animal for light vs. dark conditions.
Number of voids per 24 h (daily) and per 12 h (dark, light).
Cumulative urine weight per 24 h (daily) and per 12 h (dark, light).
Average power in the bursting frequency range expressed as percent of average total power for all voiding events.
Cumulative time during the void in which the bursting power exceeds the power in the same range, expressed as percentage of total power of amplitude-matched non-voiding epochs, by ±2 SD.
Average frequency with highest power in bursting frequency range from all spectra calculated during the void.